We found that levels of markers of inflammation (IL-6, Figure 8G; TNF-α, Figure 8H) and neurodegeneration (NfL, Figure 8I) were already elevated in ALS mice treated with vehicle by the first assessed time point of 2 months of age. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.